CAN1012 Treatment for Pre-cancerous Mouth Tissue Changes
Part of Mouth & dental clinical trials.
This study tests a new drug called CAN1012 to treat oral epithelial dysplasia, which are pre-cancerous changes in the mouth lining. The goal is to see if this drug can help prevent these changes from becoming cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with oral epithelial dysplasia (abnormal cell growth in your mouth)
- You are at least 18 years old and able to understand and follow study instructions
- You are generally healthy enough for the study, as determined by your doctor
- Your blood counts and kidney/liver function are within acceptable ranges
- If you can become pregnant, you must use effective birth control during treatment and for 5+ months after your last dose
- You don't have serious medical or mental health conditions that would make the study unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different treatments for people with oral cancer or precancerous lesions that have a p53 mutation. It aims to find the best approach for early-stage disease to prevent progression.
This trial tests a new drug called CAN1012 in people with pre-cancerous breast conditions called DCIS or LCIS. It aims to see if the drug can help before invasive cancer develops.
This Phase 2 trial studies whether APG-157 can safely improve abnormal cells in the mouth (dysplasia) or early cancer-like changes (carcinoma in situ). You may be eligible if you have a visible, biopsy-proven lesion and can take oral medication while meeting blood and health requirements.
This study looks at tissue and blood samples from people with mouth conditions that could become cancer or are already cancer. It aims to learn more about these conditions to improve diagnosis and treatment.
This Phase 2 study tests medicines given before surgery for stage III/IV oral squamous cell carcinoma, choosing the treatment based on your tumor marker results. It aims to shrink the cancer and improve outcomes by using two targeted types of therapy.
This research study examines how oral cancer develops by collecting tissue samples from people with oral cancer or pre-cancerous mouth conditions. The goal is to understand what changes happen in the mouth that lead to cancer, which may help improve diagnosis and treatment in the future.
Hear when a new Oral Epithelial Dysplasia (OED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.